North West London Referral Guidance · PDF file1. Dyspepsia pathway Dyspepsia A group of...
date post
10-Mar-2019Category
Documents
view
215download
0
Embed Size (px)
Transcript of North West London Referral Guidance · PDF file1. Dyspepsia pathway Dyspepsia A group of...
Gastroenterology October 2018
Version 1 (4 October 2018)
North West London
Referral Guidance
GASTROENTEROLOGY REFERRAL GUIDELINES These guidelines are intended to replace all existing guidelines for this specialty.
This guidance does not replace any guidance issued in relation to Planned Procedures With a Threshold (PPWT).
Name of Guideline: Gastroenterology referral guidelines
Date of issue: 29/08/2018
Signed off by:
Sign-off by lead Provider
and CCG Clinical Leads.
Named Consultant
Lead:
Dr Ana Wilson Named Primary Care
Lead:
Dr Shantha Sethurajan
Signed:
Ana Wilson Signed:
Shantha Sethurajan
Dated: 29/08/2018 Dated: 29/08/2018
Approved by members
of the Outpatient Board
on:
19/09/2018
Guidelines available
via:
EMIS, SYSTM1,
https://www.healthiernorthwestlondon.nhs.uk/referral-guidelines/xx-emis-guide-accessing-guidelines
Version: 1
Date of 6 week review: 19/10/2018
Date of next routine
review:
29/08/2021
https://www.healthiernorthwestlondon.nhs.uk/referral-guidelines/xx-emis-guide-accessing-guidelineshttps://www.healthiernorthwestlondon.nhs.uk/referral-guidelines/xx-emis-guide-accessing-guidelineshttps://www.healthiernorthwestlondon.nhs.uk/referral-guidelines/xx-emis-guide-accessing-guidelineshttps://www.healthiernorthwestlondon.nhs.uk/referral-guidelines/xx-emis-guide-accessing-guidelineshttps://www.healthiernorthwestlondon.nhs.uk/referral-guidelines/xx-emis-guide-accessing-guidelineshttps://www.healthiernorthwestlondon.nhs.uk/referral-guidelines/xx-emis-guide-accessing-guidelineshttps://www.healthiernorthwestlondon.nhs.uk/referral-guidelines/xx-emis-guide-accessing-guidelineshttps://www.healthiernorthwestlondon.nhs.uk/referral-guidelines/xx-emis-guide-accessing-guidelineshttps://www.healthiernorthwestlondon.nhs.uk/referral-guidelines/xx-emis-guide-accessing-guidelineshttps://www.healthiernorthwestlondon.nhs.uk/referral-guidelines/xx-emis-guide-accessing-guidelineshttps://www.healthiernorthwestlondon.nhs.uk/referral-guidelines/xx-emis-guide-accessing-guidelineshttps://www.healthiernorthwestlondon.nhs.uk/referral-guidelines/xx-emis-guide-accessing-guidelines
3
NWL Gastroenterology transformation working group The gastroenterology transformation working group was attended by gastroenterology consultant leads from each NWL Trust, GP clinical leads from each NWL CCG, patient representatives and management staff from the CCGs and Trusts.
Members of the gastroenterology transformation working group are:
Name Position Organisation
Dr Ana Wilson Consultant Gastroenterologist
London NW University Hospitals
NHS Trust
Dr Shantha Sethurajan General Practitioner
Hounslow CCG
Dr Afsana Safa General Practitioner
Central London CCG
Dr Bob Grover Consultant Gastroenterologist The Hillingdon Hospitals NHS Trust
Eimear Finn
Dietetics Lead
Imperial College Healthcare NHS
Trust
Dr Jas Gill General Practitioner Hillingdon CCG
Dr Martin Benson Consultant Gastroenterologist Chelsea & Westminster Foundation
Trust
Dr Mona Vaidya General Practitioner Central London CCG
Dr Pritpal Ruprai General Practitioner Hammersmith and Fulham CCG
Dr Vijay Tailor General Practitioner Ealing CCG
Dr William Howson Consultant Gastroenterologist Imperial College Healthcare NHS
Trust
Dr Evangelos Russo
Consultant Gastroenterologist
Imperial College Healthcare NHS
Trust
4
Important notice
This guidance is intended to support general practice. The guidance has been developed after careful consideration of the information and clinical opinion available to the speciality transformation working group, including consultant and GP leads for NW London Trusts and CCGs. Whilst it has been produced with significant input from clinicians, it provides general advice only and does not replace any part of a clinicians responsibility to assess each clinical case on its own merits, when exercising their clinical judgement. The CCG will not, therefore, accept liability for any loss, damage or inconvenience arising as a consequence of any use of or the inability to use any information in this guidance.
This guidance is not intended to be used as a performance management resource.
4
Referral guidelines list
1. Dyspepsia
2. Change in bowel habit
3. Abnormal LFTs
4. Hepatitis C
5. Primary Care IBD Management
6. Isolated rectal bleeding
7. Family history of bowel cancer
1. Dyspepsia pathway
Dyspepsia
A group of symptoms that alert doctors to consider disease of the upper GI tract
including:
Upper abdominal pain/ discomfort
Heartburn
Gastric reflux
Nausea or Vomiting
Post-prandial fullness
Early satiation
GORD: Endoscopically determined oesophagitis or non-erosive reflux disease
1. REFERRAL FOR ENDOSCOPY: RED FLAG SYMPTOMS AND SIGNS REFER FOR URGENT ENDOSCOPY
(within 2 weeks).
1. History of non-acute
haematemesis
OR
2. Dysphagia, especially progressive
OR
3. Age >55 and unexplained weight
loss, and any of :
1. Upper abdominal pain
2. Reflux
3. Dyspepsia
If endoscopy reveals concerning
pathology, the patient will be
managed as per local two-week wait
pathway.
OTHER SYMPTOMS
REFER FOR
NON-URGENT ENDOSCOPY
(within 6 weeks):
1. Persistent dyspepsia after PPI
therapy and H.Pylori eradication
AND/OR
a history of any of:
Barretts oesophagus
Intestinal metaplasia
Dysplasia
Recent NSAID use
Previous gastric surgery
Strong family history
2. Raised platelets with nausea or
vomiting.
Lifestyle advice:
Healthy eating, smoking cessation, weight loss, avoidance of common precipitants
(e.g. smoking, alcohol, coffee, chocolate, fatty foods)
Medication review:
NSAIDS, corticosteroids, calcium antagonists, bisphosphonates, nitrates,
theophyllines and SSRIs
Test for H. Pylori:
Stool antigen testing
Empirical full-dose PPI:
for 4 weeks for people with dyspepsia
4 8 weeks for reflux
Eradicate H. Pylori:
Two weeks of triple therapy.
N.B. No routine re-testing is recommended: only re-test eradication according to
PHE guidelines (see link).
If dyspepsia recurs off PPI, identify minimum effective maintenance dose
(including prn strategies)
Long term, full dose PPI post oesophageal stricture dilatation or
severe oesophagitis
Consider H2 blocker treatment if refractory to PPI
2. MANAGEMENT IN PRIMARY CARE:
1. Persistent symptoms and failure to eradicate H. Pylori
2. When oesophageal physiologic testing is contemplated
(e.g prior to Nissens fundoplication)
3. REASONS TO REFER TO SECONDARY CARE
See also:
1. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management Published
September 2014, NICE guideline CG184.
www.nice.org.uk/guidance/cg184/
2. PHE Test and Treat Helicobacter pylori in dyspepsia:
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/633673/Helicob
acter_pylori_Quick_Reference_Guide.pdf
3. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults:
https://www.cag-acg.org/images/publications/Hp_Toronto_Consensus_2016.pdf
NW London Gastroenterology Referral Guidance -Version1.0 4 October 18
http://www.nice.org.uk/guidance/cg184/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/633673/Helicobacter_pylori_Quick_Reference_Guide.pdfhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/633673/Helicobacter_pylori_Quick_Reference_Guide.pdfhttps://www.cag-acg.org/images/publications/Hp_Toronto_Consensus_2016.pdfhttps://www.cag-acg.org/images/publications/Hp_Toronto_Consensus_2016.pdfhttps://www.cag-acg.org/images/publications/Hp_Toronto_Consensus_2016.pdf
Any RED FLAG / HIGH risk features (listed
below)?
Any age with suspicious abdominal or
rectal mass
Any age with unexplained anal mass or
ulceration
40 years with unexplained abdominal
pain and weight loss
40 years with unexplained iron deficiency
anaemia
50 years with rectal bleeding with any of
the following unexplained symptoms:
Abdominal pain
Change in bowel habit
Weight loss
Iron deficiency anaemia
50 years with unexplained rectal bleeding
50 years with unexplained abdominal
pain or weight loss
50 years with unexplained change in
bowel habit
60 years with unexplained anaemia even
in the absence of iron deficiency
REFER via
2WW
No
Yes
2. Change in bowel habit pathway
PROBABLE IBS
If no red flags and all tests normal PAT